title: Maxitrol-induced corneal melts after routine cataract surgery in rheumatology patients.
authors.affiliation: Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK.
authors.forename: David
authors.initials: D
authors.lastname: Lockington
authors.forename: Rishi
authors.initials: R
authors.lastname: Sharma
authors.forename: Sanjay
authors.initials: S
authors.lastname: Mantry
authors.forename: Kanna
authors.initials: K
authors.lastname: Ramaesh
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003316:Corneal Diseases / Q000139:chemically induced*; D004338:Drug Combinations; D005260:Female; D005477:Fluprednisolone / Q000009:adverse effects*; D006801:Humans; D019654:Lens Implantation, Intraocular; D008297:Male; D009355:Neomycin / Q000009:adverse effects*; D009883:Ophthalmic Solutions / Q000009:adverse effects; D018918:Phacoemulsification; D011112:Polymyxin B / Q000009:adverse effects*; D012859:Sjogren's Syndrome / Q000150:complications*
chemical_list: D004338:Drug Combinations; D009883:Ophthalmic Solutions; C049064:Maxitrol; D005477:Fluprednisolone; D009355:Neomycin; D011112:Polymyxin B